Albireo Pharma Inc. buy melinda
Start price
08.08.18
/
50%
€26.46
Target price
10.08.18
€28.86
Performance (%)
9.92%
End price
10.08.18
€29.09
Summary
This prediction ended on 10.08.18 with a price of €29.09. With a performance of 9.92%, the BUY prediction by melinda for Albireo Pharma Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Albireo Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
According to melinda what are the pros and cons of Albireo Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Albireo Pharma Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 07/08 Publication de résultats
Albireo Pharma, Inc. is a pharmaceutical company, which engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders.
Its product pipeline includes A4250, Elobixibat, and A3384.
The company was founded by Jan Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
Nombre d'employés : 22 personne
Stopped prediction by melinda for Albireo Pharma Inc.
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€26.40
12.10.21
12.10.21
€29.00
12.10.22
12.10.22
-15.27%
13.10.22
13.10.22
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€30.49
04.04.19
04.04.19
€35.00
04.11.21
04.11.21
-1.61%
01.07.21
01.07.21
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€22.55
02.02.19
02.02.19
€29.00
13.03.19
13.03.19
12.55%
13.03.19
13.03.19
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€30.70
20.04.18
20.04.18
€45.10
10.07.18
10.07.18
7.70%
10.07.18
10.07.18
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€25.28
23.10.17
23.10.17
€27.06
05.01.18
05.01.18
7.88%
05.01.18
05.01.18
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€19.71
15.08.17
15.08.17
€24.81
30.08.17
30.08.17
17.39%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€21.85
15.08.17
15.08.17
€27.50
30.08.17
30.08.17
17.39%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€21.30
01.07.17
01.07.17
€22.00
05.07.17
05.07.17
3.47%
05.07.17
05.07.17
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€19.21
01.07.17
01.07.17
€19.84
05.07.17
05.07.17
3.47%
05.07.17
05.07.17
Could be worthwhile Investment >10% per year
Albireo Pharma Inc.
Start price
Target price
Perf. (%)
€364.80
14.10.10
14.10.10
€540.00
14.04.11
14.04.11
-47.70%
14.04.11
14.04.11
Could be worthwhile Investment >10% per year